Literature DB >> 10662256

Physicians' perspectives on communicating prescription drug information.

J M McGrath1.   

Abstract

Physician-patient communication has been identified as one factor that influences prescription drug compliance rates, even though the nature of such communication has not been well described. This study used a qualitative approach (in-depth interviews with 20 physicians representing a variety of medical areas) to better understand the process by which physicians communicate prescription drug information to their patients. A content analysis of interview transcripts indicated that two-way interactions focusing on the specific needs of the patients should be encouraged over simply disseminating more and more information about prescriptions. Information regarding unlikely outcomes was suggested to cause patient anxiety, which might be tied to decreased compliance rates. Physicians stressed the importance of "patient-directed communication" and expressed their concern over what they considered to be inappropriate sources of drug information. Other specific reasons cited for noncompliance included forgetfulness, ignoring medication when feeling better, and apprehensions about side effects.

Entities:  

Mesh:

Year:  1999        PMID: 10662256     DOI: 10.1177/104973299129122243

Source DB:  PubMed          Journal:  Qual Health Res        ISSN: 1049-7323


  10 in total

1.  New prescriptions: how well do patients remember important information?

Authors:  Derjung M Tarn; Susan A Flocke
Journal:  Fam Med       Date:  2011-04       Impact factor: 1.756

2.  Which providers should communicate which critical information about a new medication? Patient, pharmacist, and physician perspectives.

Authors:  Derjung M Tarn; Debora A Paterniti; Bradley R Williams; Camille S Cipri; Neil S Wenger
Journal:  J Am Geriatr Soc       Date:  2009-01-17       Impact factor: 5.562

Review 3.  A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordance.

Authors:  Fiona A Stevenson; Kate Cox; Nicky Britten; Yenal Dundar
Journal:  Health Expect       Date:  2004-09       Impact factor: 3.377

4.  An efficacy trial of an electronic health record-based strategy to inform patients on safe medication use: The role of written and spoken communication.

Authors:  Laura M Curtis; Rebecca J Mullen; Allison Russell; Aimee Fata; Stacy C Bailey; Gregory Makoul; Michael S Wolf
Journal:  Patient Educ Couns       Date:  2016-07-02

5.  Intervention to enhance communication about newly prescribed medications.

Authors:  Derjung M Tarn; Debora A Paterniti; Deborah K Orosz; Chi-Hong Tseng; Neil S Wenger
Journal:  Ann Fam Med       Date:  2013 Jan-Feb       Impact factor: 5.166

6.  Primary care physicians' prevention counseling with patients with multiple morbidity.

Authors:  Shoshana H Bardach; Nancy E Schoenberg
Journal:  Qual Health Res       Date:  2012-08-27

7.  Enhancing provision of written medicine information in Australia: pharmacist, general practitioner and consumer perceptions of the barriers and facilitators.

Authors:  Kim K Hamrosi; David K Raynor; Parisa Aslani
Journal:  BMC Health Serv Res       Date:  2014-04-23       Impact factor: 2.655

8.  How do physicians and trainers experience outcome-based education in "Rational prescribing"?

Authors:  Hamideh M Esmaily; Rezagoli Vahidi; Niaz Mousavian Fathi; Rolf Wahlström
Journal:  BMC Res Notes       Date:  2014-12-23

Review 9.  How to meet patients' individual needs for drug information - a scoping review.

Authors:  Marcel Kp Kusch; Walter E Haefeli; Hanna M Seidling
Journal:  Patient Prefer Adherence       Date:  2018-11-06       Impact factor: 2.711

10.  Factors associated with medication information in diabetes care: differences in perceptions between patients and health care professionals.

Authors:  Gerda Längst; Hanna Marita Seidling; Marion Stützle; Dominik Ose; Ines Baudendistel; Joachim Szecsenyi; Michel Wensing; Cornelia Mahler
Journal:  Patient Prefer Adherence       Date:  2015-10-14       Impact factor: 2.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.